Portfolio company
MicThera AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops microbial-inspired drug candidates and discovery platforms to treat drug-resistant prostate cancer and infectious diseases for the healthcare sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Third Arc Bio
This biotechnology company develops multifunctional antibodies to treat solid tumours and inflammatory diseases for the healthcare sector.
Oncopeptides AB
This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.
Actithera
This biotechnology company develops targeted radioligand therapies to treat cancer patients by delivering radioactive isotopes directly to solid tumours.
Discuva
This biotechnology company develops novel antibiotics to treat multi-drug resistant bacterial infections for pharmaceutical partners and healthcare providers.
Eradivir
This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.
NXThera
This company develops water vapour therapy systems to treat patients suffering from enlarged prostate and prostate cancer.
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
Rezo Therapeutics
This biotechnology company develops drug discovery platforms and targeted therapies for oncology and other serious diseases, serving the pharmaceutical and healthcare industries.
